Clinical Trial of mRNA Universal Influenza Vaccine Candidate Begins
https://clinicaltrials.gov/ct2/show/NCT05755620
Clinical trial, experimental universal influenza vaccine
National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center (VRC),
(part of National Institutes of Health)
Enrolling volunteers, Duke University, Durham, North Carolina
Phase 1 trial
H1ssF-3928 mRNA-LNP, for safety and ability to induce an immune response.
The post Experimental influenza vaccine appeared first on TheWatchTowers.org.
